Intralesional Cidofovir for the Treatment of Severe Juvenile Recurrent Respiratory Papillomatosis: Long‐Term Results in 4 Children

Abstract

Intralesional cidofovir may provide benefit in reducing the rate of RRP growth while under treatment, but RRP severity returned to pretreatment levels once cidofovir treatment was stopped using this treatment program.